中国医药导刊
中國醫藥導刊
중국의약도간
CHINESE JOURNAL OF MEDICAL GUIDE
2015年
3期
235-236
,共2页
结核性胸膜炎%糖尿病%临床特点
結覈性胸膜炎%糖尿病%臨床特點
결핵성흉막염%당뇨병%림상특점
Tuberculous pleurisy%Diabetes%Clinical features
目的:探讨糖尿病(DM)合并结核性胸膜炎患者的临床特点及治疗方法。方法:将67例DM合并结核性胸膜炎患者纳入观察组(A组),选择同期收治的73例结核性胸膜炎患者作为对照组(B组),两组均进行常规治疗,A组同时进行胰岛素治疗,比较两组观察对象的主要临床症状、并发症及合并症、住院时间及胸水吸收等情况。结果:A组以胸痛、乏力、胸闷为主,结核性胸膜炎患者以胸闷、发热、气短为主;A组主要的并发症及合并症为心脑血管疾病、肺炎等,B组主要以肺内结核为主;治疗2周后,A组胸水完全吸收者13例,B组胸水完全吸收者31例,两组比较差异有统计学意义(χ2=5.19,P<0.05);A组患者治疗后平均住院(34.8±3.4)天,B组平均(17.6±4.1)天;治疗6个月后,A组导致胸膜肥厚粘连26例,形成脓胸者2例;B组胸膜肥厚粘连11例,无脓胸发生,两组比较差异有统计学意义(χ2=4.23,P<0.05)。结论:DM合并结核性胸膜炎应对DM和结核性胸膜炎同时治疗,从而达到满意的效果。
目的:探討糖尿病(DM)閤併結覈性胸膜炎患者的臨床特點及治療方法。方法:將67例DM閤併結覈性胸膜炎患者納入觀察組(A組),選擇同期收治的73例結覈性胸膜炎患者作為對照組(B組),兩組均進行常規治療,A組同時進行胰島素治療,比較兩組觀察對象的主要臨床癥狀、併髮癥及閤併癥、住院時間及胸水吸收等情況。結果:A組以胸痛、乏力、胸悶為主,結覈性胸膜炎患者以胸悶、髮熱、氣短為主;A組主要的併髮癥及閤併癥為心腦血管疾病、肺炎等,B組主要以肺內結覈為主;治療2週後,A組胸水完全吸收者13例,B組胸水完全吸收者31例,兩組比較差異有統計學意義(χ2=5.19,P<0.05);A組患者治療後平均住院(34.8±3.4)天,B組平均(17.6±4.1)天;治療6箇月後,A組導緻胸膜肥厚粘連26例,形成膿胸者2例;B組胸膜肥厚粘連11例,無膿胸髮生,兩組比較差異有統計學意義(χ2=4.23,P<0.05)。結論:DM閤併結覈性胸膜炎應對DM和結覈性胸膜炎同時治療,從而達到滿意的效果。
목적:탐토당뇨병(DM)합병결핵성흉막염환자적림상특점급치료방법。방법:장67례DM합병결핵성흉막염환자납입관찰조(A조),선택동기수치적73례결핵성흉막염환자작위대조조(B조),량조균진행상규치료,A조동시진행이도소치료,비교량조관찰대상적주요림상증상、병발증급합병증、주원시간급흉수흡수등정황。결과:A조이흉통、핍력、흉민위주,결핵성흉막염환자이흉민、발열、기단위주;A조주요적병발증급합병증위심뇌혈관질병、폐염등,B조주요이폐내결핵위주;치료2주후,A조흉수완전흡수자13례,B조흉수완전흡수자31례,량조비교차이유통계학의의(χ2=5.19,P<0.05);A조환자치료후평균주원(34.8±3.4)천,B조평균(17.6±4.1)천;치료6개월후,A조도치흉막비후점련26례,형성농흉자2례;B조흉막비후점련11례,무농흉발생,량조비교차이유통계학의의(χ2=4.23,P<0.05)。결론:DM합병결핵성흉막염응대DM화결핵성흉막염동시치료,종이체도만의적효과。
Objective: To investigate diabetes mellitus (DM) clinical characteristics and treatment of patients with tuberculous pleurisy. Methods:67 cases of DM complicated with tuberculosis pleurisy patients into observation group (A group), 73 cases of tuberculous pleurisy patients treated during the same period were selected as control group (group B), two groups were carried out with conventional treatment, A group at the same time insulin therapy, the main clinical symptoms, compared two groups of complications and complications, hospitalization time and hydrothorax absorption etc.Results: In A group with chest pain, fatigue, chest tightness, tuberculous pleurisy patients with chest tightness, shortness of breath, fever mainly; A group of major complications and comorbidities for cardiovascular and cerebrovascular diseases, such as pneumonia, group B mainly to pulmonary tuberculosis mainly; 2 weeks after the treatment, A group of pleural effusion completely absorbed in 13 cases, B group of pleural effusion completely absorbed in 31 cases, there was significant difference between two groups (χ2=5.19,P<0.05); group A patients after treatment, the average hospitalization (34.8±3.4) days, B group of average (17.6±4.1) days; after 6 months of treatment, group A lead to pleural thickening and adhesion in 26 cases, 2 cases of empyema; pleural thickening and adhesion in 11 cases in group B, no empyema occurred, there was signiifcant difference between two groups (χ2=4.23,P<0.05).Conclusions:DM complicated with tuberculous pleurisy response to DM and tuberculosis pleurisy treat at the same time, so as to achieve satisfactory results.